GH vs. GKOS: Guardant Health vs. Glaukos Stock Comparison

Company Profile

Guardant Health (GH) and Glaukos (GKOS) both fall under the Health Care Equipment & Services industry group, but GH is classified in Health Care Providers & Services while GKOS is classified in Health Care Equipment & Supplies.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Guardant Health (GH) has an aggressive beta of 1.69, indicating higher sensitivity to broad-market moves, while Glaukos (GKOS) is defensive at 0.68 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Guardant Health (GH) has no ROE value reported for this period; Glaukos (GKOS) reports a negative figure of -22.84%, which needs context because negative ROE can reflect losses or negative shareholders’ equity.

Both Guardant Health (GH) at -37.93% and Glaukos (GKOS) at -24.60% report negative net margin values, usually indicating net losses over the period.

Guardant Health (GH) reports a negative operating margin of -37.06%, usually indicating that operating costs exceeded revenue at the operating-income line. Meanwhile Glaukos (GKOS) reports 0.39%, ranking against industry peers normally.

Profitability Metrics

Growth

Both Guardant Health (GH) at 32.88% and Glaukos (GKOS) at 32.33% sit in the top peer quartile for revenue growth, so each is growing its top line faster than typical industry peers.

Neither Guardant Health (GH) nor Glaukos (GKOS) reports a EPS growth value for this period, so a direct comparison isn't possible.

Growth Metrics

Financial Strength

Guardant Health (GH) at 3.60 keeps current ratio within its industry’s typical mid-range, while Glaukos (GKOS) at 4.57 sits above its industry’s typical mid-range — comfortable liquidity, though possibly with more idle current assets relative to peers.

Only one side’s leverage can be read here: Glaukos (GKOS) carries debt-to-equity ratio of 0.15 against its industry range, while Guardant Health (GH) reports no figure this period.

Financial Strength Metrics

Dividends

Neither Guardant Health (GH) nor Glaukos (GKOS) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Neither Guardant Health (GH) nor Glaukos (GKOS) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Dividend Metrics

Valuation

Neither Guardant Health (GH) nor Glaukos (GKOS) reports a P/E ratio value for this period, so a direct comparison isn’t possible.

Investors are paying well above the peer range per dollar of sales for both Guardant Health (GH) at 15.96 and Glaukos (GKOS) at 19.24 — each P/S ratio clears its industry’s benchmark range.

Guardant Health (GH) reports a negative P/B ratio of -73.67, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile Glaukos (GKOS) reports 18.51, ranking against industry peers normally.

Valuation Metrics